Shares of Bioventix PLC (LON:BVXP – Get Free Report) passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 1,914.65 and traded as low as GBX 1,450. Bioventix shares last traded at GBX 1,608, with a volume of 44,755 shares trading hands.
Bioventix Stock Performance
The firm has a market capitalization of £85.64 million, a PE ratio of 11.44 and a beta of 0.53. The business’s 50 day moving average is GBX 1,607.88 and its two-hundred day moving average is GBX 1,912.74.
Bioventix (LON:BVXP – Get Free Report) last issued its earnings results on Monday, March 30th. The biotechnology company reported GBX 69.38 earnings per share (EPS) for the quarter. Bioventix had a net margin of 57.83% and a return on equity of 67.14%. The business had revenue of GBX 615.88 billion for the quarter. As a group, equities research analysts predict that Bioventix PLC will post 166.3066955 EPS for the current year.
Bioventix Company Profile
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants. It also provides contract SMAs and recombinant services. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom.
See Also
Receive News & Ratings for Bioventix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioventix and related companies with MarketBeat.com's FREE daily email newsletter.
